Jacob M. Rowe

机构：Technion – Israel Institute of Technology, Rambam Health Care Campus, Shaare Zedek Medical Center · ORCID：0000-0002-2016-2918

发表论文 540 篇 · 总被引 27397 次 · h-index 83

代表论文

• SINGLE CELL DISSECTION OF DEVELOPMENTAL ORIGINS AND TRANSCRIPTIONAL HETEROGENEITY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 17)
• S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910 (2023 · HemaSphere · 被引 17)
• Assessment of Outcomes of Consolidation Therapy By Number of Cycles of Blinatumomab Received in Newly Diagnosed Measurable Residual Disease Negative Patients with B-Lineage Acute Lymphoblastic Leukemia: In the ECOG-ACRIN E1910 Randomized Phase III National Clinical Trials Network Trial (2023 · Blood · 被引 14)
• What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission? (2023 · Journal of Clinical Oncology · 被引 11)
• Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study (2023 · Bone Marrow Transplantation · 被引 7)
• War and peace: Israeli physicians treating Palestinian patients (2023 · The Lancet · 被引 5)